Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA blood glucose test strip alert not received by 38% of pharmacists in OIG survey.

This article was originally published in The Tan Sheet

Executive Summary

FDA BLOOD GLUCOSE TEST STRIP ALERT MISSED BY 38% OF PHARMACISTS surveyed via phone by HHS' Office of the Inspector General, according to a July 17 OIG report. Examining the effectiveness of an Oct. 11, 1995 FDA safety alert on defective blood glucose test strips manufactured by Diagnostic Solutions, the OIG audit of 462 pharmacies nationwide found that just over 60% of the vendors "acknowledged receiving" the FDA notice.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085915

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel